ENZ (Enzo Biochem) Company Net Assets

Public company logo of Enzo (ENZ)

The available price action for Enzo Biochem, Inc. (ENZ) reflects the dynamics of a diversified business that combines diagnostic services with the production of molecular components to mitigate market volatility. The company's liquidity currently stands at 0.05, which, following the divestment of certain assets, allows for the development of patents without financial distress. A strategic alliance with research centers helps the brand implement advanced research methods within clinics.

ENZ Enzo Biochem Inc. Book Capitalization (07/04/2022 - 04/26/2025)
Flagship merchandise of Enzo Biochem

Book value is calculated as the difference between total assets and liabilities, reflecting the actual value of net resources used to protect capital from inflationary risks. The stable dynamics of the balance sheet capital structure confirm the financial stability of Enzo Biochem, Inc. (ENZ), reinforcing its high authority in the field of molecular diagnostics and guaranteeing the reliability of investments in proven medical standards.

Competitor analysis

A: Net Asset Value|DGX (Quest Diagnostics) - Company Book Value|illumina.com (ILMN) - Company Net Assets|Book Capitalization EXAS (Exact Sciences Corporation)|Total Stockholders' Equity Revvity Inc|Book Capitalization Bio-Rad Laboratories Inc BIO|Accounting Capitalization Anbio Corp (NNNN)|Book Capitalization SHC (Sotera Health Company)|quidel.com - Book Capitalization|OPKO Health (OPK) - Company Book Value|CDNA - Accounting Capitalization|MRVI: Book Capitalization|FLGT (Fulgent) - Book Capitalization|Company Book Value Standard BioTools Inc.|Company Book Value cytekbio.com (CTKB)|OraSure - Company Net Assets|Total Stockholders' Equity XGN (exagen.com)|Company Book Value MDXH|Book Valuation of Business Lucid Diagnostics, Inc LUCD|Book Capitalization PRE (Prenetics Global Ltd)|IMDX: Book Valuation of Business|trinitybiotech.com - Company Book Value|ProPhase Labs Inc (PRPH) - Book Valuation of Business|Book Capitalization AIMD (Ainos Corp)|Total Stockholders' Equity CODX|Company Book Value Heart Test Laboratories HSCS|Accounting Capitalization biomerica.com BMRA|Cardio Diagnostics Holdings (CDIO) - Company Net Assets|Virax Biolabs Group Limited - Net Asset Value|BJDX (Bluejay) - Company Book Value|Aspira Women's Health Inc (AWH) - Total Stockholders' Equity|Company Net Assets Accelerate Diagnostics AXDX|CENTOGENE (CNTG) - Accounting Value of Company|Book Capitalization Fresh2 Group Ltd|Company Book Value GTG Labs|ME (23andMe Inc.) - Book Capitalization|Book Valuation of Business PMD (Psychemedics Inc)